WO2001034550A3 - 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders - Google Patents
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders Download PDFInfo
- Publication number
- WO2001034550A3 WO2001034550A3 PCT/US2000/029234 US0029234W WO0134550A3 WO 2001034550 A3 WO2001034550 A3 WO 2001034550A3 US 0029234 W US0029234 W US 0029234W WO 0134550 A3 WO0134550 A3 WO 0134550A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- dry eye
- metabolic stability
- treating dry
- acid analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU80314/00A AU8031400A (en) | 1999-11-09 | 2000-10-23 | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16437499P | 1999-11-09 | 1999-11-09 | |
US60/164,374 | 1999-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001034550A2 WO2001034550A2 (en) | 2001-05-17 |
WO2001034550A3 true WO2001034550A3 (en) | 2001-12-13 |
Family
ID=22594202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/029234 WO2001034550A2 (en) | 1999-11-09 | 2000-10-23 | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
Country Status (3)
Country | Link |
---|---|
US (2) | US6320062B1 (en) |
AU (1) | AU8031400A (en) |
WO (1) | WO2001034550A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003030894A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
WO2003105831A1 (en) * | 2002-06-14 | 2003-12-24 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
US20030236284A1 (en) * | 2002-06-14 | 2003-12-25 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness |
US20040002514A1 (en) * | 2002-06-14 | 2004-01-01 | Alcon, Inc. | Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis |
JP2006502183A (en) * | 2002-09-20 | 2006-01-19 | アルコン,インコーポレイテッド | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
US9289494B2 (en) * | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059964A1 (en) * | 1998-05-15 | 1999-11-25 | University Of Vermont | Novel analogs of 16-hydroxyeicosatetraenoic acid |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
AU546872B2 (en) | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
US4421748A (en) | 1982-07-13 | 1983-12-20 | Trager Seymour F | Artificial tear aid |
GB8319073D0 (en) | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
US4868154A (en) | 1986-02-19 | 1989-09-19 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with melanocyte stimulating hormones |
US4753945A (en) | 1986-02-19 | 1988-06-28 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with phosphodiesterase inhibitors |
US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US4921644A (en) | 1988-02-29 | 1990-05-01 | Technology Unlimited, Inc. | Mucin directed lipsome |
US4906467A (en) | 1988-03-24 | 1990-03-06 | New York Medical College | Novel, long-duration treatment for glaucoma |
US4923700A (en) | 1988-06-03 | 1990-05-08 | Kaufman Herbert E | Artificial tear suspension |
US5064655A (en) | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
AU655919B2 (en) | 1990-02-22 | 1995-01-19 | Macnaught Pty Limited | Artificial tears |
US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
EP0459148B1 (en) | 1990-05-29 | 1996-01-03 | Ocular Research Of Boston Inc. | Dry eye treatment composition |
ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
US5102670A (en) | 1990-09-14 | 1992-04-07 | Abraham Nader G | Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels |
DE69212850T2 (en) | 1991-01-15 | 1997-03-06 | Alcon Lab Inc | Use of carrageenan in topical ophthalmic compositions |
ZA927277B (en) | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
EP0546728A3 (en) | 1991-12-13 | 1993-09-08 | Alcon Laboratories Inc | Physiological tear compositions and methods for their preparation |
ES2139005T3 (en) | 1992-04-21 | 2000-02-01 | Schepens Eye Res Inst | EYE THERAPY WITH ANDROGEN IN SJOGREN'S SYNDROME. |
US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
US5358706A (en) | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5389383A (en) | 1993-06-18 | 1995-02-14 | Allergan, Inc. | Method for treating hypoxia-associated ocular complications |
US5696166A (en) | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
US6087325A (en) | 1996-10-15 | 2000-07-11 | The Liposome Company, Inc. | Peptide-lipid conjugates |
US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
-
2000
- 2000-10-23 WO PCT/US2000/029234 patent/WO2001034550A2/en active Application Filing
- 2000-10-23 AU AU80314/00A patent/AU8031400A/en not_active Abandoned
- 2000-10-23 US US09/694,584 patent/US6320062B1/en not_active Expired - Fee Related
-
2001
- 2001-07-11 US US09/903,259 patent/US6348496B1/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059964A1 (en) * | 1998-05-15 | 1999-11-25 | University Of Vermont | Novel analogs of 16-hydroxyeicosatetraenoic acid |
Non-Patent Citations (4)
Title |
---|
A.S. SUBBARAMAN ET AL: "A facile racemic synthesis of eicosane-1,16-diol, an aglycone of a marine natural product forbesin", INDIAN JOURNAL OF CHEMISTRY, vol. 31B, no. 4, 1992, pages 262 - 263, XP001002142 * |
J. A. FINDLAY ET AL: "Forbesin: A novel sulfated glycolipid from the starfish Asterias Forbesi", JOURNAL OF NATURAL PRODUCTS, vol. 53, no. 4, 1990, pages 1015 - 1018, XP001002172 * |
J. DAN AND S. THAKUR: "Constituent acids of Cucumis sativus Fruit Cutin", ASIAN JOURNAL OF CHEMISTRY, vol. 7, no. 2, 1995, pages 381 - 388, XP001002140 * |
L. MORRIS ET AL: "Chromatographic behaviour of isomeric long-chain aliphatic compounds", JOURNAL OF CHROMATOGRAPHY, vol. 33, no. 3-4, 1968, pages 471 - 479, XP001002120 * |
Also Published As
Publication number | Publication date |
---|---|
US6320062B1 (en) | 2001-11-20 |
US6348496B1 (en) | 2002-02-19 |
WO2001034550A2 (en) | 2001-05-17 |
AU8031400A (en) | 2001-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1045986A1 (en) | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders. | |
CA2234367A1 (en) | Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders | |
AU3920900A (en) | Compounds and methods to treat cardiac failure and other disorders | |
HK1057214A1 (en) | New mandelic acid derivatives and their use as throbin inhibitors | |
AU2002239830A1 (en) | Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof | |
PL343685A1 (en) | 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases | |
MXPA02004701A (en) | Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders. | |
WO2001034550A3 (en) | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders | |
MXPA02004702A (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use. | |
AU2003294856A1 (en) | Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders | |
BR0314804A (en) | Modified Release Dosage Form | |
HK1057332A1 (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
WO2001034546A3 (en) | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye | |
WO2001034548A3 (en) | 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use | |
WO2001034553A3 (en) | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use | |
AU2001283199A1 (en) | Methods and compositions for the diagnosis and treatment of brown adipose cell disorders | |
WO2001034547A3 (en) | 15-hydroxyeicosatetraenoic acid-related compounds and methods of use | |
HK1045983A1 (en) | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders. | |
AU3971600A (en) | Use of osanetant in the production of medicaments used to treat mood disorders | |
AU3356000A (en) | L-arginine based formulations for treating diseases and methods of using same | |
WO2000007541A3 (en) | Use of xanthine derivatives for treating erectile disorder | |
WO2002013825A8 (en) | Novel pharmaceutical use of quinnoline derivatives | |
MEP20308A (en) | THE USE OF R(+)-alpha-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS | |
DK1228030T3 (en) | Benzene derivatives of 15-hydroxyyeocosatetraenoic acid and methods for their use in the treatment of dry eye disorders | |
AU4101900A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN JP KR MX PL TR US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA CN JP KR MX PL TR US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |